Fesoterodine in Patients with Overactive Bladder Syndrome; Potential Biomarkers

Trial Profile

Fesoterodine in Patients with Overactive Bladder Syndrome; Potential Biomarkers

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Oct 2015

At a glance

  • Drugs Fesoterodine (Primary)
  • Indications Overactive bladder
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 27 Oct 2015 published in Yonsei Med J. 2015 Jan;56(1):204-211
    • 27 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top